Cumberland Pharmaceuticals Inc (CPIX): Gross Profit
$37.85M
Year ended 2025-12-31
+4.8%
3-year compound annual growth
| Period ended | Gross Profit | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $37.85M | +21.0% | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | $31.28M | -6.6% | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | $33.49M | +1.8% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $32.89M | n/c | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $26.23M | -3.5% | 2023-03-13, From 2021-01-01 |
| 2020-12-31 | $27.19M | +8.8% | 2022-03-11, From 2020-01-01 |
| 2019-12-31 | $24.99M | +9.7% | 2022-03-11, From 2019-01-01 |
| 2018-12-31 | $22.79M | n/c | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | $33.01M | +24.5% | 2020-03-20, From 2017-01-01 |
| 2016-12-31 | $26.52M | n/a | 2019-03-12, From 2016-01-01 |
Gross Profit at similar companies
| Company | Year ended | Gross Profit | Change YoY |
|---|---|---|---|
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $37.85M | +21.0% |
| Aquestive Therapeutics, Inc. (AQST) | 2025-12-31 | $25.99M | -34.5% |
| Integrated Biopharma Inc (INBP) | 2026-06-30 | $800.0K | -85.6% |
| Ocular Therapeutix, Inc (OCUL) | 2025-12-31 | $45.38M | -21.9% |
| BGM Group Ltd. (BGM) | 2025-09-30 | $6.31M | +53.4% |
| Lftd Partners Inc. (LIFD) | 2025-12-31 | $12.62M | -1.1% |
| Agios Pharmaceuticals, Inc. (AGIO) | 2025-12-31 | $47.68M | +47.5% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $12.26M | +14.9% |
| Nektar Therapeutics (NKTR) | 2024-12-31 | $67.74M | +20.2% |
Compare CPIX, AQST, INBP, OCUL side by side · Screen every company in Pharmaceutical Preparations ↗